The report provides a comprehensive summary of the non-injectable insulin market, along with detailed profiles of key market players that include revenue product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities.
The report discusses strategies adopted by emerging market players, with recommendations for new market entrants. This research study discusses historical, current and potential market size.
The report will help market players and new entrants make informed decisions about the production and export of goods and services. Organizations, distributors and exporters should find the information about market development and trends useful. The study segments the market according to applications and end-uses. Geographical market analysis is provided for all major segments.
The report includes:
An overview of the global market for non-injectable insulin
Analyses of market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
Information on recent major technical advances in different forms of non-injectable insulin
A look at the key areas of growth and adoption rate of non-injectable insulin among both commercial customers and regulatory authorities
Examination of strategies of the major players in the market and the impact of new technological developments
Key Topics Covered
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Future Market Potential and Investment Analysis
North America Will Be the Largest and Fastest-Growing Market
Chapter 4 Market Breakdown by Form
Pills
Spray
Others (Film and Chewing Gum)
Chapter 5 Market Breakdown by Source
Synthetic Insulin
Semisynthetic Insulin
Chapter 6 Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Landscape
Chapter 8 Company Profiles
Access Pharmaceuticals Inc. (Abeona Therapeutics Inc.)
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference.
On April 26, 2024, the hearing will commence 11:15 a.m.
Members of the public may observe the hearing by videoconference, by...
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...